Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers
22 nov. 2022 10h47 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and STAMFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, and BEKHealth, a leading clinical...
Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials
17 nov. 2022 08h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and OSAKA, Japan, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, and Linical Americas, a U.S. subsidiary of...
Science 37 Named Best in Class for Telehealth Innovation at UCSF Health Hub Digital Health Awards 2022
15 nov. 2022 17h00 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, was named as winner in the Telehealth Innovation category at...
Science 37 Reports Third Quarter 2022 Financial Results
10 nov. 2022 16h01 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial...
Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
01 nov. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022...
Science 37 appoints Paul von Autenried to its Board of Directors
05 oct. 2022 16h15 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the appointment of seasoned...
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
12 sept. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced that Michael Shipton has been...
Science 37 to Present at the Baird 2022 Global Healthcare Conference
08 sept. 2022 16h01 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be...
Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials
07 sept. 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C. and BOSTON, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced a partnership with...
New Science 37 Technology Accelerates Patient Recruitment and Enrollment
24 août 2022 07h55 HE
|
Science 37, Inc.
RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) today announced new patient relationship management and contact center technology to improve...